UB Paderborn / Katalog / Suche / in CDI

1 – 15 von 15

Sortiert nach

SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control

Nature reviews cardiology, 2020-12, Vol.17 (12), p.761-772

2020

Link zum Volltext

Verfügbarkeit prüfen

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial

The Lancet (British edition), 2012-04, Vol.379 (9825), p.1489-1497

2012

Link zum Volltext

Verfügbarkeit prüfen

Increasing Physical Activity in People With Type 2 Diabetes

Diabetes care, 2003-04, Vol.26 (4), p.1186-1192

2003

Link zum Volltext

Verfügbarkeit prüfen

2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

European journal of preventive cardiology, 2016-07, Vol.23 (11), p.NP1-NP96

2016

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Factors Related to Glycemic Management in Professional Cyclists With Type 1 Diabetes Over a 7-Day Stage Race

Diabetes care, 2020-05, Vol.43 (5), p.1142-1145

2020

Link zum Volltext

Verfügbarkeit prüfen

Diabetes and atherogenesis

Heart (British Cardiac Society), 2004-03, Vol.90 (3), p.336-340

Fisher, Miles

2004

Link zum Volltext

Verfügbarkeit prüfen

Diabetes, left ventricular systolic dysfunction, and chronic heart failure

European heart journal, 2008-05, Vol.29 (10), p.1224-1240

2008

Link zum Volltext

Verfügbarkeit prüfen

A post‐hoc pooled analysis to evaluate the risk of hypoglycaemia with insulin glargine 300 U/mL (Gla‐300) versus 100 U/mL (Gla‐100) over wider nocturnal windows in individuals with type 2 diabetes on a basal‐only insulin regimen

Diabetes, obesity & metabolism, 2019-02, Vol.21 (2), p.402-407

2019

Link zum Volltext

Verfügbarkeit prüfen

Diabetes: can we stop the time bomb?

Heart (British Cardiac Society), 2003-05, Vol.89 (suppl 2), p.ii28-30; discussion ii35-7

Fisher, M

2003

Link zum Volltext

Verfügbarkeit prüfen

Glycaemic control and hypoglycaemia in people with type 2 diabetes switching from twice‐daily basal insulin to once‐daily insulin glargine 300 U/mL or insulin glargine 100 U/mL (EDITION 1 and EDITION 2 subgroup analysis)

Diabetes, obesity & metabolism, 2018-02, Vol.20 (2), p.448-452

2018

Link zum Volltext

Verfügbarkeit prüfen

Reuse of disposable plastic insulin syringes

BMJ (Online), 1991-08, Vol.303 (6797), p.286

1991

Link zum Volltext

Verfügbarkeit prüfen

Hyperglycemic crises in adult patients with diabetes

Diabetes care, 2009-07, Vol.32 (7), p.1335-1343

2009

Link zum Volltext

Verfügbarkeit prüfen

The sensitivity of interferon-gamma release assays is not compromised in tuberculosis patients with diabetes

The international journal of tuberculosis and lung disease, 2011-02, Vol.15 (2), p.179

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 15 von 15

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieThe British Journal Of Diabetes & Vascular Disease

KollektionMEDLINE

ThemaDiabetes

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(13)
Mit Volltextzugriff
(12)

Publikationsform

Artikel
(15)

Sprache

Englisch
(15)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(15)
Life Sciences & Biomedicine
(12)
Science & Technology
(12)
Risk Factors
(7)
Adult
(6)
Biological And Medical Sciences
(6)
Medical Sciences
(6)
Blood Pressure
(5)
Cardiac & Cardiovascular Systems
(5)
Cardiovascular System & Cardiology
(5)
Insulin
(5)
Male
(5)
Blood Glucose - Metabolism
(4)
Diabetes Mellitus
(4)
Diabetes. Impaired Glucose Tolerance
(4)
Endocrine Pancreas. Apud Cells
(4)
Endocrinology & Metabolism
(4)
Endocrinopathies
(4)
Female
(4)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial

Increasing Physical Activity in People With Type 2 Diabetes

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

Evaluation of Factors Related to Glycemic Management in Professional Cyclists With Type 1 Diabetes Over a 7-Day Stage Race

Diabetes and atherogenesis

Diabetes, left ventricular systolic dysfunction, and chronic heart failure

A post‐hoc pooled analysis to evaluate the risk of hypoglycaemia with insulin glargine 300 U/mL (Gla‐300) versus 100 U/mL (Gla‐100) over wider nocturnal windows in individuals with type 2 diabetes on a basal‐only insulin regimen

Diabetes: can we stop the time bomb?

Glycaemic control and hypoglycaemia in people with type 2 diabetes switching from twice‐daily basal insulin to once‐daily insulin glargine 300 U/mL or insulin glargine 100 U/mL (EDITION 1 and EDITION 2 subgroup analysis)

Reuse of disposable plastic insulin syringes

Hyperglycemic crises in adult patients with diabetes

The sensitivity of interferon-gamma release assays is not compromised in tuberculosis patients with diabetes

Aktive Filter

Suchergebnisse filtern